Samonte, Ma. Gwyneth .
HRN: 15-52-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2022
CEFUROXIME 1.5GM (VIAL)
07/10/2022
07/16/2022
IVT
375mg
Q8
T/c UTI, Pneumonia
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary TractPneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes